External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL

Clinical trial NCT07528352 · RECRUITING

Trial details

NCT number: NCT07528352
Sponsor: University of Utah
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2026-06-01
Primary completion: 2030-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.